Takuji Okusaka

20PUBLICATIONS
94CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersLiquid biopsiesCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Oct 12, 2026
Recent advances in systemic therapy for biliary tract cancer: Evidence from Japan and recommendations in guidelines.

|Sep 23, 2026
Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract Cancer.

|Jul 28, 2025
Modified Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin or S-1, Irinotecan, and Oxaliplatin Versus Nab-Paclitaxel + Gemcitabine in Metastatic or Recurrent Pancreatic Cancer (GENERATE, JCOG1611): A Randomized, Open-Label, Phase II/III Trial.

Akihiro Ohba, Masato Ozaka, Junki Mizusawa

|Jun 26, 2025
First Successful Treatment of Advanced Intrahepatic Cholangiocarcinoma with Tasurgratinib Following Regulatory Approval: A Case Report from Clinical Practice.

Yuta Maruki, Chigusa Morizane, Mao Okada

|Feb 23, 2025
NALIRIFOX in Japanese treatment-naïve patients with metastatic pancreatic adenocarcinoma: an open-label, phase II trial design.

Masafumi Ikeda, Takuji Okusaka, Makoto Ueno

|Aug 29, 2024
Utility of Transpapillary Biopsy and Endoscopic Ultrasound-Guided Tissue Acquisition for Comprehensive Genome Profiling of Unresectable Biliary Tract Cancer.

Soma Fukuda, Susumu Hijioka, Yoshikuni Nagashio

Pageof 4

Frequent Collaborators

5 joint publications

Junji Furuse

5 joint publications

Susumu Hijioka

5 joint publications

Makoto Ueno

5 joint publications

Masafumi Ikeda